Ixabepilone Ixempra 45mg Injection

Get a Price/Quote

MOQ : 100 Boxes

Ixabepilone Ixempra 45mg Injection Specification

Indication
Breast Cancer, especially metastatic or locally advanced breast cancer after failure of anthracycline and taxane therapy

Salt Composition
Ixabepilone

Dosage Form
Injection

Feature
For Intravenous Infusion Only; potent mitotic inhibitor for cancer therapy

Application
Antineoplastic Agent (Cancer treatment)

Physical Color/Texture
Clear to slightly yellow solution

Storage Instructions
Store below 25C (77F). Do not freeze. Protect from light.

Shelf Life
Check package for expiry date, generally 24 months from manufacturing

Contraindications
Patients with hypersensitivity to Ixabepilone or formulation components

Common Side Effects
Neutropenia, peripheral neuropathy, fatigue, myalgia, nausea, vomiting

Route of Administration
Intravenous infusion

Pack Size
Single-use vial

Usage Restriction
For hospital and oncology specialist administration only

Country of Approval
Approved in Canada, Europe, UK, USA, Australia

Diluent Required
Reconstitute with supplied diluent before IV infusion

Prescription Status
Prescription Only

Strength
45 mg per vial

Ixabepilone Ixempra 45mg Injection Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Ixabepilone Ixempra 45mg Injection About

Buy online Ixabepilone Ixempra 45mg Injection, a scarce and highly valuable cancer treatment trusted by healthcare professionals worldwide. This top-drawer antineoplastic agent is indicated for metastatic or locally advanced breast cancer, particularly after anthracycline and taxane therapies have been exhausted. With stellar results in clinical practice, each single-use vial (45 mg) is supplied for intravenous infusion, requiring dilution prior to administration. Ixempra is approved across Canada, Europe, the UK, USA, and Australia, adding significant value for hospitals and oncology specialists. For prescription use only-ensure patient eligibility before ordering.

Specialized Use and Clinical Advantages

Ixabepilone Ixempra 45mg Injection is designed for hospital-based or oncology specialist administration via intravenous infusion. Its specific use is in treating metastatic or locally advanced breast cancer, especially when standard therapies have failed. The advantage of Ixempra lies in its potent mitotic inhibition, offering hope in difficult-to-treat cases. This product exemplifies a valuable, precision-targeted therapy-providing clinicians with a stellar tool in advanced cancer management.

Efficient Supply and Secure Packaging

Shipped goods are promptly dispatched throughout India's main domestic market, ensuring you receive your order securely and efficiently. Ixabepilone Ixempra 45mg Injection is carefully packed in single-use vials, each with a clear to slightly yellow solution. Packing & dispatch procedures prioritize product stability: stored under 25C, protected from light, and never frozen. Every shipment includes detailed packaging specifications and shelf-life information, guaranteeing reliability from supplier to end user.

FAQ's of Ixabepilone Ixempra 45mg Injection:

Q: How should Ixabepilone Ixempra 45mg Injection be prepared and administered?

A: Ixabepilone Ixempra 45mg Injection must be reconstituted with the supplied diluent before intravenous infusion. It is intended for hospital or oncology specialist use only, administered under strict medical supervision.

Q: What type of cancer is Ixabepilone Ixempra 45mg Injection used for?

A: This injection is specifically indicated for metastatic or locally advanced breast cancer, particularly in patients who have not responded to anthracycline and taxane therapies.

Q: When should Ixabepilone Ixempra not be used?

A: Ixabepilone should not be used in patients with known hypersensitivity to Ixabepilone or any of its formulation components. Always review contraindications with your healthcare provider before use.

Q: Where is Ixabepilone Ixempra 45mg Injection approved and available?

A: Ixempra is approved for prescription use in Canada, Europe, the UK, USA, and Australia, and is supplied primarily within the Indian domestic market by licensed manufacturers, suppliers, and traders.

Q: What are the main side effects associated with this medication?

A: Common side effects include neutropenia, peripheral neuropathy, fatigue, myalgia, nausea, and vomiting. Consult your physician about managing these effects and when to seek medical attention.

Q: How is the product shipped and stored to maintain quality?

A: The injection is shipped in single-use vials, packed securely to stay below 25C, protected from light, and is never frozen, ensuring product stability upon arrival.

Tell us about your requirement